Preclinical Evidence for GLP-1 Agonists in Alcohol Use Disorder
Rodent studies show GLP-1 drugs reduce alcohol intake by dampening reward signals in the brain.
Kwame Sinclair
Correspondent
Kwame Sinclair
Kwame Sinclair is a correspondent at Pathway in Peptides covering glp-1 neurology. Based in New York, Kwame has written for Pathway in Peptides since 2023.
1 story · New York